These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 34959116)
1. A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies. Li CX; Noreen S; Zhang LX; Saeed M; Wu PF; Ijaz M; Dai DF; Maqbool I; Madni A; Akram F; Naveed M; Li JH Biomed Pharmacother; 2022 Feb; 146():112550. PubMed ID: 34959116 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies. Gong W; Parkkila S; Wu X; Aspatwar A Int Rev Immunol; 2023; 42(6):393-414. PubMed ID: 35635216 [TBL] [Abstract][Full Text] [Related]
3. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity. Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P Cells; 2021 Oct; 10(11):. PubMed ID: 34831172 [TBL] [Abstract][Full Text] [Related]
4. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far. Khan M; Adil SF; Alkhathlan HZ; Tahir MN; Saif S; Khan M; Khan ST Molecules; 2020 Dec; 26(1):. PubMed ID: 33374759 [TBL] [Abstract][Full Text] [Related]
5. Human and novel coronavirus infections in children: a review. Rajapakse N; Dixit D Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199 [TBL] [Abstract][Full Text] [Related]
6. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2. Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096 [TBL] [Abstract][Full Text] [Related]
7. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses. Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205 [TBL] [Abstract][Full Text] [Related]
8. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359 [TBL] [Abstract][Full Text] [Related]
9. Current Strategies of Antiviral Drug Discovery for COVID-19. Mei M; Tan X Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887 [TBL] [Abstract][Full Text] [Related]
10. Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2. Bilal M; Iqbal HMN Hum Vaccin Immunother; 2020 Dec; 16(12):3034-3042. PubMed ID: 32845742 [TBL] [Abstract][Full Text] [Related]
11. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development. Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK Front Immunol; 2020; 11():1880. PubMed ID: 32973779 [TBL] [Abstract][Full Text] [Related]
12. Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children. Zimmermann P; Curtis N Pediatr Infect Dis J; 2020 May; 39(5):355-368. PubMed ID: 32310621 [TBL] [Abstract][Full Text] [Related]
13. The immunology of SARS-CoV-2 infection, the potential antibody based treatments and vaccination strategies. Payandeh Z; Mohammadkhani N; Nabi Afjadi M; Khalili S; Rajabibazl M; Houjaghani Z; Dadkhah M Expert Rev Anti Infect Ther; 2021 Jul; 19(7):899-910. PubMed ID: 33307883 [No Abstract] [Full Text] [Related]
14. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. To KK; Sridhar S; Chiu KH; Hung DL; Li X; Hung IF; Tam AR; Chung TW; Chan JF; Zhang AJ; Cheng VC; Yuen KY Emerg Microbes Infect; 2021 Dec; 10(1):507-535. PubMed ID: 33666147 [TBL] [Abstract][Full Text] [Related]
15. Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies. Bian L; Gao F; Zhang J; He Q; Mao Q; Xu M; Liang Z Expert Rev Vaccines; 2021 Apr; 20(4):365-373. PubMed ID: 33851875 [TBL] [Abstract][Full Text] [Related]
16. The novel zoonotic COVID-19 pandemic: An expected global health concern. Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085 [TBL] [Abstract][Full Text] [Related]
17. Outbreak of COVID-19: An emerging global pandemic threat. Peng M Biomed Pharmacother; 2020 Sep; 129():110499. PubMed ID: 32768974 [TBL] [Abstract][Full Text] [Related]
18. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). Shanmugaraj B; Siriwattananon K; Wangkanont K; Phoolcharoen W Asian Pac J Allergy Immunol; 2020 Mar; 38(1):10-18. PubMed ID: 32134278 [TBL] [Abstract][Full Text] [Related]
19. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection. Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH Front Immunol; 2020; 11():1022. PubMed ID: 32574260 [TBL] [Abstract][Full Text] [Related]
20. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants. Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM Elife; 2022 Aug; 11():. PubMed ID: 36004719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]